Mongaya, Rio D.
HRN: 21-16-82 Sex: MalePatient Encounter
Audit Details
Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
01/17/2024
METRONIDAZOLE 5MG/ML, 100ML (VIAL)
01/17/2024
01/24/2024
IV
200mg
Q8H
T/c Fournier’s Gangrene; Infected Wound
Waiting Final Action
Indication: Empiric Type of Infection: Skin & Soft Tissue Compliance to guidelines: Compliant To Guidelines
Initial appropriateness: Yes
Final appropriateness: Yes
Overall appropriateness: Yes